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Staphylococcus aureus is a versatile pathogen causing a wide range of infections. It has
been a major threat both in hospitals and in the community for decades. S. aureus is a
pyogenic bacterium that elicits recruitment of polymorphonuclear leukocytes (neutrophils)
to the site of infection. Neutrophils are among the first immune cells to migrate to
an infection site attracted by chemoattractant gradients, usually initiated in response
to inflammation. Neutrophil recruitment to an inflammation and/or infection site is a
sophisticated process involving their interaction with endothelial and epithelial cells
through adhesion molecules. Phagocytes have various receptors to detect pathogens, and
they include Toll-like receptors (TLRs). TLRs have been extensively studied over the last 10
years and it is now established that they are critical during bacterial infections. However,
the function of TLRs, and more particularly TLR2, during staphylococcal infections is still
debated. In this review we will consider recent findings concerning the staphylococcal
ligands sensed by TLR2 and more specifically the role of staphylococcal lipoproteins
in TLR2 recognition. A new concept to emerge in recent years is that staphylococcal
components must be phagocytosed and digested in the phagosome to be efficiently
detected by the TLR2 of professional phagocytes. Neutrophils are an essential part of the
immune response to staphylococcal infections, and in the second part of this review we
will therefore describe the role of TLR2 in PMN recruitment in response to staphylococcal
infections.
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INTRODUCTION
Staphylococcus aureus is a commensal, especially well-adapted to
humans, also able to cause a wide range of infectious diseases
from minor cutaneous infections to more severe infections such
as sepsis, pneumonia, osteomyelitis, and endocarditis. It also fre-
quently infects surgical wounds and medical implants [reviewed
in Lowy (1998)]. S. aureus has become increasingly resistant to
antibiotics in recent years and about 55% of healthcare-associated
(formerly hospital-acquired) isolates are now resistant to methi-
cillin (methicillin-resistant S. aureus, MRSA) [reviewed in Calfee
(2012) and Gould et al. (2012)]. Mostly found in hospitals 20
years ago, MRSA strains have now spread to the community with
virulent strains causing necrotizing pneumonia and other severe
infections (David and Daum, 2010; Otter and French, 2011).
Commensal S. aureus is found mainly in the anterior nares and
about one third of the populations are permanent asymptomatic
carriers. S. aureusmay also colonize skin, perineum, gastrointesti-
nal tract, and throat [reviewed in Tong et al. (2012)]. S. aureus has
a formidable repertoire of virulence factors: cell-surface proteins
(including protein A) and numerous secreted virulence factors
(for example proteolytic enzymes and cytotoxins) contribute to
the development of infections by promoting bacterial adhesion,
circumventing host immune defenses and causing cell or tissue
damage [reviewed in Projan and Novick (1997), Foster (2005),
Ben Zakour et al. (2008), Otto (2010), Cheng et al. (2011), and
Edwards and Massey (2011)]. Virulence factors are crucial for
development of staphylococcal infections; however, host-related
determinants, such as immune competence, also play an essential
role in infection (Tong et al., 2012). S. aureus induces a signif-
icant recruitment of leucocytes. Phagocytes, like most immune
cells, use pattern recognition receptors (PRRs) to detect and dif-
ferentiate microorganisms from self. These receptors include the
Toll-like receptors (TLRs) which are transmembrane proteins
capable of recognizing conserved structures of pathogens, the so-
called pathogen-associated molecular patterns (PAMPs). When
these pathogen molecules bind to TLRs, a cascade of protein
activation results in the activation of NF-κB and activator pro-
tein 1, transcriptional factors that promote cytokine production
[reviewed in Takeda and Akira (2004) and Oliveira-Nascimento
et al. (2012)]. One of the best-characterized TLRs is TLR2 which
initiates responses against a wide range of ligands (Ozinsky et al.,
2000; Takeuchi et al., 2001, 2002; Sandor et al., 2003). The litera-
ture contains diverse descriptions of the function of TLRs during
staphylococcal infections. We will review the most recent findings
concerning the staphylococcal ligands detected by TLR2 and the
role of phagocytosis in TLR2 sensing. We will also consider what
is known about the contribution of TLR2 to the recruitment of
neutrophils during staphylococcal infections.
ROLE OF LIPOPROTEINS IN TLR2-MEDIATED SENSING
OF S. aureus
WHAT DOWE KNOWABOUT STAPHYLOCOCCAL TLR2 LIGANDS?
TLR2 can recognize ligands with very diverse structures
such as lipoproteins/lipopeptides, peptidoglycan, glycopolymers
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[lipoteichoic acid (LTA) and lipoarabinomannan], and proteins
(porins, virus capsids) [reviewed in Zahringer et al. (2008) and
Oliveira-Nascimento et al. (2012)]. The wide range of TLR2 lig-
ands is partly due to its heterodimerization with co-receptors
described to expand the spectrum of stimuli recognized by TLR2
without altering the signaling pathways used (Farhat et al., 2008).
TLR2 associated with TLR1 senses triacyl lipopeptides/proteins
(represented by the synthetic triacylated lipopeptide, Pam3-Cys-
Ser-Lys4, Pam3CSK4) (Figure 1A) whereas an association with
TLR6 is required to recognize diacyl lipoproteins (Pam2CSK4
or MALP2) (Ozinsky et al., 2000; Takeuchi et al., 2001, 2002;
Takeda et al., 2002). Binding of Pam3CSK4 induces a confor-
mational change of the ectodomains of both TLR1 and TLR2,
resulting in the formation of a heterodimer. Pam2CSK4 does
not promote this conformation and therefore does not activate
TLR2-TLR1 (Jin et al., 2007). TLR2 may detect other staphy-
lococcal PAMPs: peptidoglycan, a large polymer constituting
the main component of the Gram-positive cell wall, and LTA
(the counterpart of LPS in Gram-positive bacteria) [reviewed in
Fournier and Philpott (2005)] although the relevance is contro-
versial as the concentrations of peptidoglycan and LTA necessary
to trigger TLR2 are not physiological (Zahringer et al., 2008).
Indeed TLR2 recognition of peptidoglycan has been debated
[(Travassos et al., 2004) and reviewed in Fournier and Philpott
(2005)]. It has been suggested that muramyl dipeptide, the small-
est peptidoglycan structure, is detected by an intracellular PRR,
Nod2 (nucleotide-binding oligomerization domain protein 2)
(Girardin et al., 2003). Interestingly, it was recently shown that
peptidoglycan co-localizes with both TLR2 and Nod2 after inter-
nalization. Nevertheless, the interaction of peptidoglycan with
TLR2 is not dependent on Nod2 and vice-versa (Muller-Anstett
et al., 2010). Furthermore, peptidoglycan potentializes the activ-
ity of other TLR ligands, including LTA and LPS (Volz et al., 2010).
Thus, it is possible that peptidoglycan is a weak TLR2 ligand
that contributes to host immune responses by enhancing inflam-
mation triggered by other more potent staphylococcal ligands
such as lipoproteins. In addition to TLR1 and TLR6, other acces-
sory non-TLR molecules may also serve as TLR2 co-receptors
A B
FIGURE 1 | Bacterial lipoproteins. (A) Structure of bacterial lipoproteins
according to Braun and Wu (1994). The structure of synthetic
lipopeptide Pam3CSK4 is also indicated. Triacylated bacterial lipoproteins
and Pam3CSK4 have the same lipid moiety (green). R1, R2, and R3 are
fatty acyl chains. Adapted from Braun and Wu (1994) and Chambaud
et al. (1999). (B) Biosynthesis of lipoproteins in Gram-negative and
Gram-positive bacteria. After crossing the cytoplasmic membrane Lgt
(prolipoprotein diacylglyceryl transferase) transfers a diacylglyceride to
the polypeptide chain and Lsp (lipoprotein signal peptidase) cleaves the
signal peptide. In Gram-negative bacteria Lnt (lipoprotein N-acyl
transferase) adds a third fatty acyl chain as indicated in the text.
Although triacylated lipoproteins have been described in S. aureus, the
mechanism of lipoprotein N-acylation is not known. Furthermore, in
Gram-negative bacteria, acylated lipoproteins are translocated to the
outer membrane by the Lol system [Reviewed in Okuda and Tokuda
(2011)].
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[reviewed in Oliveira-Nascimento et al. (2012)]. CD36, an inte-
gral membrane scavenger receptor, appears to have a role in
LTA recognition and S. aureus phagocytosis (Hoebe et al., 2005;
Stuart et al., 2005; Triantafilou et al., 2006; Baranova et al., 2008;
Nilsen et al., 2008) although it is not clear how important this
receptor is for the immune response against S. aureus (Baranova
et al., 2008). CD36-deficient mice present an increased suscepti-
bility to S. aureus and various TLR2 ligands including LTA and
MALP2 (Hoebe et al., 2005). In contrast to other TLR2 accessory
molecules, mannose-binding lectin (MBL) is a soluble humoral
PRR that binds to the carbohydrate moieties of microorganisms
in an EDTA-specific manner and in the case of S. aureus, LTA
[reviewed in Ip et al. (2009)]. MBL-deficient mice are more sus-
ceptible than wild-type mice to S. aureus septicemia (Shi et al.,
2004) and MBL has been reported to enhance S. aureus phago-
cytosis (Neth et al., 2002; Krarup et al., 2005; Ip et al., 2008).
Indeed, the serum level of a wide array of cytokines (TNFα,
RANTES, MIP-2, MCP-1, KC, IFNγ) is decreased in MBL-
deficient mice compared to wild-type mice following S. aureus
intravenous challenge (Ip et al., 2008). CD36 and MBL both bind
to LTA but they interact independently with TLR2 (Ip et al.,
2008).
Bacterial lipoproteins were first found to activate TLR2 in
1999 (Aliprantis et al., 1999) and are among the most potent
staphylococcal components known to activate TLR2 (Hashimoto
et al., 2006a,b). There is increasing evidence that lipoproteins
play an important role in TLR2 activation by staphylococci.
Lipoproteins of Gram-negative bacteria are sorted to the inner
and outer membranes separated by the periplasm and are also
found in the outer leaflet of the outer membrane (Figure 1B)
(Okuda and Tokuda, 2011). In contrast, lipoproteins of Gram-
positive bacteria are only attached into the outer leaflet of
the plasma membrane and are present in a subcellular space
comprised between the plasma membrane and the peptido-
glycan [reviewed in Hutchings et al. (2009)]. Lipoproteins are
very abundant in bacteria, and make up about 2–3% of the
bacterial proteome [reviewed in Hutchings et al. (2009)]. The
typical structure of Gram-positive lipoprotein was determined
in Braun and Wu (1994) (Figure 1A). Lipoprotein biosynthe-
sis is a multistep process (Figure 1B). The proteins are first
exported across the plasma membrane as preproteins; pro-
lipoprotein diacylglyceryl transferase (Lgt) then transfers a diacyl
glyceride to the lipobox cysteine residue in the protein sig-
nal peptide and lipoprotein signal peptidase (Lsp) cleaves the
signal peptide. In Gram-negative bacteria, lipoprotein N-acyl
transferase (Lnt) adds a third fatty acyl chain to the same
lipobox, thereby generating a triacylated lipoprotein [reviewed
in Hutchings et al. (2009)] (Figure 1B). As Gram-positive bac-
teria do not possess the lnt gene, it was presumed that they
contained mainly diacylated lipoproteins. However, recent data
suggest that triacylated lipoproteins are also present in S. aureus:
indeed staphylococcal lipoprotein SitC has three fatty acids
(Kurokawa et al., 2009). SitC-stimulated macrophages produce
TNFα and IL-6 in a TLR2- and MyD88-dependent but TLR1-
and TLR6-independent manner. However, SitC is not as potent
as Pam3CSK4 (Kurokawa et al., 2009). Interestingly, sitC− strains
can still activate TLR2, implicating other staphylococcal ligands
including other lipoproteins in TLR2 activation (Kurokawa et al.,
2009). Both diacylated and triacylated lipoproteins have been
described in S. aureus (Tawaratsumida et al., 2009; Asanuma
et al., 2011). A very recent study reported that lipoprotein pro-
duction is modulated by environmental conditions and this may
explain why both diacylated and triacylated lipropoteins have
been described in S. aureus. Indeed, diacylated forms of lipopro-
teins are found mainly when the bacteria are in the stationary
growth phase or at acidic pH indicating that growth conditions
determine lipoprotein acylation in staphylococci (Kurokawa et al.,
2012).
An lgt-deficient S. aureus mutant displays membrane-
anchored lipoproteins without the lipid groups, and the full
lipoproteins are detected mainly in the culture supernatant (Stoll
et al., 2005). The TLR2-dependent production of cytokines
(TNFα, IL-10, IL-6, IL-8, and MIP2) in various cell types
(mononuclear, epithelial, and endothelial cells) in response to
this mutant was very much lower than that in response to the
wild type (Stoll et al., 2005; Schmaler et al., 2009; Kang et al.,
2011). However, in vivo studies with a murine model of sep-
ticemia are contradictory: in one study, the S. aureus lgt− mutant
was more virulent than the WT strain (Bubeck Wardenburg
et al., 2006), whereas another study reports lower virulence
for this mutant (Schmaler et al., 2009). These various findings
nevertheless indicate that staphylococcal lipoproteins are criti-
cal for the innate immune response through TLR2. However,
the exact role of lipoproteins in vivo, and whether lipopro-
teins are indeed necessary for staphylococcal infections, remain
unclear.
ROLE OF PHAGOCYTOSIS IN TLR2 SENSING
Phagocytosis of pathogens by professional phagocytes is a key
step in innate immunity. Phagocyte receptors (Fc receptors, com-
plement receptors, integrins, scavenger receptors among others)
recognize bacteria opsonized with immunoglobulins, comple-
ment, or extracellular matrices e.g., fibronectin [Reviewed in
Underhill and Ozinsky (2002)]. After major rearrangements of
the actin cytoskeleton, phagocytes internalize bacteria (Underhill
and Ozinsky, 2002). TLRs are not phagocytic receptors per se,
but they are also internalized in the process and therefore par-
ticipate to the link between phagocytosis and inflammatory
responses by triggering the production of cytokines (Underhill
and Ozinsky, 2002). Engulfed bacteria are transferred to phago-
somes, which fuse with other organelles (endosomes and lyso-
somes) and enzymatic complexes such as NADPH oxidase. The
result is a highly hydrolytic phagolysosome with reactive oxy-
gen species that lyses bacteria and digests their components
[reviewed in Underhill and Ozinsky (2002), Stuart and Ezekowitz
(2005), Kinchen and Ravichandran (2008), and Nordenfelt and
Tapper (2011)]. Treatment of THP-1, macrophage-like cells, with
live S. aureus increases the expression of TLR2 and MyD88
(Zarember and Godowski, 2002). Intriguingly, although MyD88-
deficient macrophages release much less cytokines than wild-
type macrophages after staphylococcal infection, TLR2-deficient
macrophages produce a significant amounts of cytokines, sug-
gesting that other receptors associated with MyD88 are involved
in Staphylococcus sensing (Takeuchi et al., 2000; Lembo et al.,
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2003). In 1999, a first study reported that TLRs were recruited
to the phagolysosomes where they were capable of differenti-
ating Gram-negative from Gram-positive pathogens to produce
cytokines (Underhill et al., 1999). Indeed, dominant-negative
inhibitor TLR2 or MyD88 introduced into macrophage-like
cells (RAW 264.7) failed to produce TNFα in response to
S. aureus infection, whereas the wild-type gene did (Underhill
et al., 1999). Other studies later suggested that there are two
modes of phagosome maturation (constitutive and inducible)
and TLRs including TLR2 may accelerate inducible matura-
tion in presence of specific ligands (Blander and Medzhitov,
2004) although this is still controversial (Yates and Russell,
2005).
Several articles demonstrate that staphylococcal degradation
in the phagosome is required for PAMP release and recogni-
tion by PRRs (Kapetanovic et al., 2007; Dietrich et al., 2010;
Ip et al., 2010; Shimada et al., 2010; Wolf et al., 2011). Thus,
phagocytosis seems to proceed in two steps. First, bacteria
are recognized by TLRs at the surface of the phagocytes and
this is not dependent on TLR ligands (Figure 2). Indeed, pep-
tidoglycan from S. aureus strains resistant to lysozyme and
from wild-type strains release similar amounts of IL-1β and
TNFα during the first hour post-infection (Shimada et al.,
2010; Wolf et al., 2011), suggesting that peptidoglycan does
not require to be degraded at this step. Second, engulfed bac-
teria are transferred into phagosomes and lysed. During this
digestion in the phagosomes, most bacterial cell-wall com-
ponents and bacterial DNA are released, resulting in mate-
rials presented to PRRs (Ip et al., 2010; Wolf et al., 2011).
Cytosolic PRRs detecting these structures are either engulfed
TLRs such as TLR2, cytosolic TLRs such as TLR9 (a recep-
tor for CpG motifs in DNA), or Nod2 depending on the
study (Kapetanovic et al., 2007; Wolf et al., 2011) (Figure 2).
Phagocytosis and digestion of pathogens therefore amplify the
immune response by presenting motifs recognized by cytoso-
lic PRRs (Wolf et al., 2011). SitC increases intracellular TLR2
and co-localizes with TLR2 (but unlike peptidoglycan, not with
Nod2) (Muller et al., 2010; Muller-Anstett et al., 2010). TLR2
and MBL have been reported to co-immunoprecipitate and also
co-localize in the phagosome. Importantly, cytochalasin D, a
phagocytosis inhibitor, suppresses MBL-induced TNFα, suggest-
ing that internalization is necessary for MLB function (Ip et al.,
2008). Thus, internalization seems to be a prerequisite for full
S. aureus-induced activation of TLR2, at least in professional
phagocyte cells.
TLR2 AND NEUTROPHIL RECRUITMENT DURING
STAPHYLOCOCCAL INFECTIONS
Polymorphonuclear cells (PMN) constitute one of the first
lines of defense against pathogens, and are thus an impor-
tant component of the innate immune response to staphylo-
coccal infections. Neutrophils are equipped with a powerful
arsenal of weapons capable of killing most pathogens includ-
ing Staphylococcus [reviewed in Miller and Cho (2011), Fournier
and Parkos (2012), and Rigby and Deleo (2012)]. Immune
diseases leading to neutropenia or neutrophil dysfunction,
such as defects of intracellular killing (chronic granulomatous
FIGURE 2 | Function of TLR2 during phagocytosis. S. aureus with
surface TLR2 ligands (lipoproteins, peptidoglycan, and LTA) is internalized in
a TLR2-independentmanner and digested in phagosomes. Staphylococcal
components are released and stimulate PRRs e.g., TLR2 or Nod2, resulting
in phagocyte activation and production of cytokines.
disease, myeloperoxidase deficiency, and glucose-6-phosphate
dehydrogenase deficiency) and degranulation (Chediak-Higashi
syndrome), or abnormal chemotaxis (leukocyte adhesion defi-
ciency, Job’s syndrome) result in recurrent staphylococcal disease
[reviewed in Lakshman and Finn (2001), Spickett (2008), Rigby
and Deleo (2012), and Tong et al. (2012)], highlighting the crit-
ical function of neutrophils in the immune response against
S. aureus. Although not directly implicating TLR2, two inter-
esting studies report that children with mutations in MyD88
and IRAK4, a protein kinase involved in TLR signaling (Takeda
and Akira, 2004), are at high risk of developing pyogenic
bacterial infections, mainly involving Gram-positive bacteria
such as staphylococci (Picard et al., 2003; Von Bernuth et al.,
2008).
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TLR2 is strongly expressed on leukocytes (mainly in periph-
eral blood, but also spleen) (Zarember and Godowski, 2002)
and its expression is increased in GM-CSF- and G-CSF (gran-
ulocyte/macrophage colony-stimulating factors)-stimulated neu-
trophils (Kurt-Jones et al., 2002; Hayashi et al., 2003). TLR2
activation also contributes to PMN stimulation. Indeed, stim-
ulation of human PMN with the TLR2 ligand Pam3CSK4
induces production of several cytokines (IL-8, MIP-1α, MIP-
1β, MIP-3α, and IL-1β) (Hayashi et al., 2003; Sabroe et al.,
2003). Activation of TLR2 by Pam3CSK4 induces L-selectin
shedding and increases CD11b expression both involved in
PMN migration. Pam3CSK4 in synergy with the bacteria-derived
chemoattractant formyl-methionyl-leucyl-phenylalanine (fMLF)
generates superoxide (Figure 2). Interestingly, neutrophils from
patients with chronic granulomatous disease presenting a defect
in oxidative metabolism do not show increased CD11b and TLR2
expression upon stimulation with Pam3CSK4 (Kobayashi et al.,
2004; Hartl et al., 2008), suggesting that oxidative metabolism is
necessary for lipoprotein effect. Furthermore, TLR2 stimulation
with Pam3CSK4 also results in increased neutrophil phagocytosis
(Hayashi et al., 2003).
The relevance of TLR2-driven immune responses dur-
ing staphylococcal infections and more particularly neutrophil
recruitment has been recently studied. TLR2 appears to con-
tribute to mouse survival in a model of Staphylococcus-induced
septicemia, but only against intravenous challenge with 107 bac-
teria (Takeuchi et al., 2000). In a murine model of staphylococcal
cutaneous infection, TLR2−/− mice have larger lesions than wild-
type mice although neutrophil recruitment was not impaired on
day 1 post-infection (Molne et al., 2000; Miller et al., 2006). Work
with murine models of staphylococcal skin infections, arthri-
tis and septicemia has led to the suggestion that IL-1R, that
also signals through MyD88, is more important than TLR2 for
neutrophil recruitment and bacterial clearance [(Hultgren et al.,
2002; Verdrengh et al., 2004; Miller et al., 2006), reviewed in Sethi
and Chakraborty (2011)]. Intriguingly, neutrophil recruitment in
a model of murine peritonitis is significantly lower in TLR2−/−
mice than in wild-type mice after 4 h, whereas no difference
was observed after 24 h (Mullaly and Kubes, 2006). In contrast,
the difference between wild-type and IL-1R-deficient mice in a
model of septicemia appeared only after 72 h (Verdrengh et al.,
2004). It is thus possible that TLR2 is involved in the very early
immune response, whereas IL-1R may take over for subsequent
PMN recruitment.
Polymicrobial infections may complicate matters further.
Indeed, staphylococcal infection following a mild or severe sys-
temic inflammatory response syndrome (SIRS) (Muckart and
Bhagwanjee, 1997) generates different subsets of neutrophils:
normal PMNs are found in untreated mice, whereas PMN-
I and -II subsets are detected in mice with mild and severe
SIRS, respectively (Tsuda et al., 2004). These subsets of neu-
trophils differ in their capacity to activate macrophages, pro-
duce cytokines and express TLRs, TLR2 mRNA being equally
abundant in all the subsets (Tsuda et al., 2004). Neutrophil
recruitment is impaired during sepsis, one of the frequent mani-
festations of staphylococcal disease (Zou et al., 2011; Kovach and
Standiford, 2012). Although the mechanisms dysregulating PMN
recruitment during sepsis are multifactorial, the massive pro-
duction of chemokines often contributes to neutrophil desensi-
tization [reviewed in Kovach and Standiford (2012)]. Neutrophil
recruitment is a multistep process initiated by the presence of
a chemoattractant gradient that guide neutrophils to the site
of inflammation [reviewed in Ley et al. (2007)]. Two recep-
tors involved in chemoattractant detection, CXCR2 and CXCR1,
are abundantly expressed at the surface of neutrophils and both
recognize two neutrophil chemoattractants, CXCL-6 (or granu-
locyte chemotactic protein-1) and CXCL-8 (also known as IL-8)
among other chemokines (Stillie et al., 2009; Stadtmann and
Zarbock, 2012). High concentration of chemoattractants dur-
ing sepsis dysregulates neutrophil sensing by down regulating
chemoattractant receptors and activating neutrophils, resulting
in impaired recruitment (Phillipson and Kubes, 2011). Indeed,
peripheral neutrophils during polymicrobial sepsis exhibit only
weak CXCR2 expression (Cummings et al., 1999) due in part to
TLR activation by microbial ligands. Lipopeptide-treated neu-
trophils exhibit decreased expression of CXCR2 and CXCR1
(Hayashi et al., 2003; Sabroe et al., 2003), with the loss of
CXCR2 expression being quicker and more substantial than that
of CXCR1 (Sabroe et al., 2005). It has also been described that
treatment with Pam3CSK4 and MALP2 diminishes neutrophil
chemotaxis toward IL-8 or fMLF (Hayashi et al., 2003; Chin et al.,
2009). Thus, decreased expression of IL-8 receptors (CXCR-1
and CXCR-2) associated with enhanced chemoattractant produc-
tion during sepsis may impair perception of chemoattractants
by PMN and thereby contribute to defective PMN chemotaxis
(Hayashi et al., 2003) (Figure 2). TLR2 activation by lipopep-
tides 24 h after a low-dose staphylococcal infection results in lethal
sepsis with increased bacterial load and a very large decrease of
neutrophil numbers (Navarini et al., 2009). Furthermore, TLR2-
deficient mice with acute polymicrobial peritonitis, induced by
cecal ligation and puncture, exhibit enhanced neutrophil migra-
tion, resulting in a decreased bacterial load and serum cytokine
production (Alves-Filho et al., 2009). Thus, TLR2 participates
actively to neutrophil stimulation and recruitment during staphy-
lococcal infections.
CONCLUSION
Staphylococcal diseases have become a significant health issue,
and there is a dearth of appropriate antibiotics to treat them.
The role of PRRs, including TLR2, during these infections is
thus of particular interest. Our knowledge of the staphylococ-
cal components involved in TLR2 recognition has improved
substantially, and lipoproteins have been shown to be among
the most potent TLR2 ligands in S. aureus. The environment-
dependent regulation of lipoprotein acylation necessary for
detection by TLR2 complicates the issue, and raises ques-
tions about how this regulation may modulate host immune
responses in vivo. Although there is a consensus concerning
the role of phagocyte TLR2, stimulated with staphylococcal lig-
ands in vitro, reports on the role of lipoproteins in murine
staphylococcal infections in vivo are more discordant. Further
in vivo studies are therefore required to elucidate lipopro-
tein function in the immune response against S. aureus. TLR2
is also a major player in staphylococcal disease through its
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diverse roles in various professional phagocyte functions: PMN
stimulation and adhesion molecule expression, chemotaxis and
chemoattractant receptor expression, and phagocytosis and lig-
and detection (Figure 2).
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